MP:0000183 | decreased circulating LDL cholesterol level | "less than average concentration in the blood of low density lipoprotein, which normally transports cholesterol to tissues other than the liver" [Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Naa40tm1Qwzh/Naa40tm1Qwzh,Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Genetic Background: B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Naa40tm1Qwzh
|
MP:0001260 | increased body weight | "greater than normal average weight " [J:33400] |
Show
Allelic Composition: Naa40tm1Qwzh/Naa40tm1Qwzh,Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Genetic Background: B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Naa40tm1Qwzh
|
MP:0001431 | abnormal eating behavior | "inability to consume or atypical consumption pattern" [Stedman s Medical Dictionary:ISBN 0-683-40008-8, MGI:cls, J:19212] |
Show
Allelic Composition: Gng3tm1.1Rbs/Gng3tm1.1Rbs,Gng7tm1Lex/Gng7tm1Lex Genetic Background: B6.Cg-Gng7tm1Lex Gng3tm1.1Rbs
|
MP:0002118 | abnormal lipid homeostasis | "anomaly in the state of equilibrium in the body with respect to lipids in the fluids and tissues" [csmith:Cynthia L. Smith , Mouse Genome Informatics Curator] |
Show
Allelic Composition: Naa40tm1Qwzh/Naa40tm1Qwzh,Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Genetic Background: B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Naa40tm1Qwzh
|
MP:0002310 | resistance to fatty liver development | "less likely than the norm to to develop hepatic steatosis " [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Naa40tm1Qwzh/Naa40tm1Qwzh,Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Genetic Background: B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Naa40tm1Qwzh
|
MP:0003960 | increased lean body mass | "more than average fat-free physical bulk or volume of the body including all its components except adipose tissue" [honda:Hiraoki Onda, Mouse GEnome Informatics Curator] |
Show
Allelic Composition: Naa40tm1Qwzh/Naa40tm1Qwzh,Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Genetic Background: B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Naa40tm1Qwzh
|
MP:0003976 | decreased circulating VLDL triglyceride level | "lower than average concentration in the blood of very low density lipoprotein, which normally transports triglycerides from the intestine and liver to muscle and adipose tissue" [brs:Beverly Richards-Smith, Mouse Genome Informatics Curator] |
Show
Allelic Composition: Naa40tm1Qwzh/Naa40tm1Qwzh,Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Genetic Background: B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Naa40tm1Qwzh
|
MP:0004889 | increased energy expenditure | "increase in the number of calories used per unit time or decrease in weight gain for a given amount of food eaten" [MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Naa40tm1Qwzh/Naa40tm1Qwzh,Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Genetic Background: B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Naa40tm1Qwzh
|
MP:0005289 | increased oxygen consumption | "greater than the normal rate at which oxygen enters the blood from alveolar gas; this is equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body" [MeSH:National Library of Medicine - Medical Subject Headings , 2003] |
Show
Allelic Composition: Naa40tm1Qwzh/Naa40tm1Qwzh,Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Genetic Background: B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Naa40tm1Qwzh
|
MP:0005292 | improved glucose tolerance | "better than the normal response to oral consumption or intravenous injection of specified amounts of glucose and indicative of insulin sensitivity; measured by determining whole blood or plasma sugar level in a fasting state before and after taking glucose at specified intervals" [MeSH:National Library of Medicine - Medical Subject Headings , 2003] |
Show
Allelic Composition: Naa40tm1Qwzh/Naa40tm1Qwzh,Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Genetic Background: B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Naa40tm1Qwzh
|
MP:0005459 | decreased percent body fat | "less fat, relative to the norm, as a percentage of total body weight" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Naa40tm1Qwzh/Naa40tm1Qwzh,Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Genetic Background: B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Naa40tm1Qwzh
|
MP:0005559 | increased circulating glucose level | "greater than the normal concentration in the blood of this major monosaccharide of the body; it is an important energy source" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator, RGD:Rat Genome Database submission] |
Show
Allelic Composition: Naa40tm1Qwzh/Naa40tm1Qwzh,Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Genetic Background: B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Naa40tm1Qwzh
|
MP:0009356 | decreased liver triglyceride level | "lower than normal concentration of triacylglycerols in the liver" [MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Naa40tm1Qwzh/Naa40tm1Qwzh,Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Genetic Background: B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Naa40tm1Qwzh
|
MP:0010025 | decreased total body fat amount | "less than the normal total amount of connective tissue composed of fat cells within the entire body" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Naa40tm1Qwzh/Naa40tm1Qwzh,Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Genetic Background: B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Naa40tm1Qwzh
|
MP:0010360 | decreased liver free fatty acids level | "reduced liver concentration of the fatty acids which occur in plasma as a result of lipolysis in adipose tissue or when plasma triacyglycerols are taken into tissues" [ISBN:0-683-40008-8 "Stedman s Medical Dictionary, 27th edition"] |
Show
Allelic Composition: Naa40tm1Qwzh/Naa40tm1Qwzh,Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Genetic Background: B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Naa40tm1Qwzh
|
MP:0010379 | decreased respiratory quotient | "reduction in the ratio of the volume of carbon dioxide released to oxygen consumed by a body tissue or an organism compared to controls" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Naa40tm1Qwzh/Naa40tm1Qwzh,Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Genetic Background: B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Naa40tm1Qwzh
|
MP:0014171 | increased fatty acid oxidation | "increased rate or incidence of the process of removal of one or more electrons from a fatty acid, with or without the concomitant removal of a proton or protons, by reaction with an electron-accepting substance, by addition of oxygen or by removal of hydrogen" [GO:0019395] |
Show
Allelic Composition: Naa40tm1Qwzh/Naa40tm1Qwzh,Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Genetic Background: B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Naa40tm1Qwzh
|